Wells Fargo & Company »

Parabilis Medicines shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Parabilis Medicines shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Parabilis Medicines

Tip: Access up to 7 years of quarterly data

All positions including Parabilis Medicines held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Parabilis Medicines by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $32k 1.2k 27.37

More positions owned by Wells Fargo & Company

Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
JPMorgan Chase & Co. (JPM)
Ishares Core Msci Emkt (IEMG)

View all positions for Wells Fargo & Company

Top funds holding Parabilis Medicines

RA Capital Management
FMR
Arch Venture Corp
venBio Partners
Alphabet
Nextech Invest
Cormorant Asset Management
Regeneron Pharmaceuticals
Siren
Farallon Capital Management
Jupiter Topco
Frazier Life Sciences Management
Deerfield Management Company
General Catalyst Group Management
General Atlantic

View all funds holding Parabilis Medicines